spacer
home > pmps > autumn 2017 > sterilisation steels
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Sterilisation Steels

Clean and safe environments are essential criteria for compliance with UK Medicines and Healthcare products Regulatory Agency (MHRA) standards. To support this, furniture and equipment must facilitate Good Manufacturing Practice. This means it must be chemically inert and robust enough to withstand thorough cleaning and maintenance.

MHRA hygiene audits are renowned for being necessarily stringent, and a clean and safe environment is the top criterion for compliance. In particular, it is important that clean rooms are designed with contamination prevention and control practices in mind. This is where stainless steel comes in. The material has been a standard feature in clean rooms and laboratories for decades.

Stainless steel is an alloy of iron that has a minimum of 10.5% chromium, which provides a supplementary ‘passive layer’ of oxide on the surface of the steel. Increasing the percentage of chromium improves corrosion resistance, and this is generally considered to be the main selling point of stainless steel. Adding elements such as manganese, molybdenum, nickel and nitrogen enhances this further and can also make the metal more malleable and thus easier to manufacture into different designs.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Sue Springett is Commercial Manager at Teknomek, which manufactures hygienic furniture and equipment. Having previously held similar positions in manufacturing and service industries, she has helped Teknomek introduce a series of new products specifically for clean room users.
spacer
Sue Springett
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

2019 IPEC Europe Annual Excipients Forum, Malta, 31 January

Join NSF at this dynamic conference in Malta on the 31st January 2019, recognised to be one of the key events for pharmaceutical excipients in Europe.
More info >>

White Papers

Device Develop for Combo Products

Phillips-Medisize

Combination products are defined as therapeutics combining two or more products (drug/device, biologics/device, biologics/drugs or drug/device/biologics), regulated and sold as a single unit. As these pharmaceutical and biological therapies and treatments have evolved, so has the need to develop appropriate delivery mechanisms for these applications. When developing a combination product, there are many things that need to be considered – the critical relationships between device development and the pharmaceutical or biologic, early establishment of regulatory and clinical strategies, understanding ‘user’ needs, determining product requirements, as well as, device manufacturing variation.
More info >>

 
Industry Events

PDA Parenteral Packaging 2019

19-20 March 2019, Hilton Molino Stucky, Venice, Italy

PDA Europe’s Conference has become a must-attend event for all professionals in the Parenteral Packaging arena. Join us in Venice in March 2019 to continue and further deepen scientific advancements and our ongoing professional discourse of latest on primary packaging technologies and business trends. This conference and the accompanying exhibition address quality of components and cont­ainers, container closure development and integrity testing as well as aspects of processing, product distribution and storage.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement